Cardio Diagnostics Holdings, Inc. (CDIO) Operating Margin
- Operating margin · 12 months: Value -44690.68%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -44690.68% | Operating income / revenue. Period ending 2026-06-30. $-6.46M ÷ $14.45K × 100 ≈ -44690.68% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -6.46M USD | Operating Income (Loss) |
| Revenue | 14.45K USD | |
| Cost of products and services | (m) | |
| Research and development | 636.60K USD | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-6.46M | $14.45K | (m) | $636.60K | (m) | -44690.68% |
| 2026-03-31 | $-6.64M | $16.57K | (m) | $652.20K | (m) | -40074.58% |
| 2025-12-31 | $-6.48M | $14.82K | (m) | $641.21K | (m) | -43737.46% |
| 2025-09-30 | $-6.54M | $15.78K | (m) | $360.10K | (m) | -41422.24% |
| 2025-06-30 | $-6.23M | $19.51K | (m) | $176.30K | (m) | -31960.98% |
| 2025-03-31 | $-5.84M | $19.90K | (m) | $20.48K | (m) | -29335.69% |
| 2024-12-31 | $-8.37M | $34.89K | (m) | $29.13K | (m) | -23977.86% |
| 2024-09-30 | $-8.39M | $35.69K | (m) | $30.86K | (m) | -23513.43% |
| 2024-06-30 | $-8.43M | $39.14K | (m) | $64.32K | (m) | -21530.73% |
| 2024-03-31 | $-9.70M | $32.99K | (m) | $69.36K | (m) | -29392.23% |
| 2023-12-31 | $-7.24M | $17.07K | (m) | $145.18K | (m) | -42440.43% |
| 2023-09-30 | $-8.08M | $12.71K | (m) | $168.78K | (m) | -63585.34% |
| 2023-06-30 | $-7.79M | $2.67K | (m) | $133.26K | (m) | -291035.59% |
| 2023-03-31 | (m) | $950.00 | (m) | $125.98K | (m) | (m) |
| 2022-12-31 | $-4.55M | $950.00 | (m) | $40.45K | (m) | -478784.32% |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |